Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.36
0.097.09%
After Hours: 9:27 AM EDT
Comments
Loading...
Aclaris Therapeutics Stock Price, Quotes and Forecasts
ACRSNASDAQ
Aclaris Therapeutics (ACRS) Forecast
NewsEarningsAclaris Therapeutics (ACRS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Aclaris Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ACRS | Benzinga
Explore Aclaris Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ACRS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aclaris Therapeutics (ACRS) stock?
You can purchase shares of Aclaris Therapeutics (NASDAQ:ACRS) through any online brokerage.
Who are Aclaris Therapeutics (ACRS) competitors?
Other companies in Aclaris Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA) and Universe Pharmaceuticals (NASDAQ:UPC).
What is the forecast, or price target, for Aclaris Therapeutics (ACRS) stock?
Aclaris Therapeutics has a consensus price target of $11.20.
What is the current price for Aclaris Therapeutics (ACRS)?
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $1.43 last updated May 28, 2025 at 3:47 PM EDT.
Does Aclaris Therapeutics (ACRS) pay a dividend?
There are no upcoming dividends for Aclaris Therapeutics.
When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?
Aclaris Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.
Is Aclaris Therapeutics (ACRS) going to split?
There is no upcoming split for Aclaris Therapeutics.
What sector and industry does Aclaris Therapeutics (ACRS) operate in?
Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
